- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2091
0 new
Companies with a Value score of at least 3, ordered by Value score
2,091 companies
Shin Nippon Biomedical Laboratories
Market Cap: €52.5b
A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.
YB3
€7.70
7D
-7.8%
1Y
-11.0%
Sage Therapeutics
Market Cap: US$455.0m
A biopharmaceutical company, develops and commercializes brain health medicines.
SAGE
US$7.54
7D
18.0%
1Y
-51.8%
Auxly Cannabis Group
Market Cap: CA$98.6m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.08
7D
14.3%
1Y
60.0%